Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 2, 2025Biomolecules and BiomedicineOpen Access

Advancing regenerative therapies with umbilical cord–derived mesenchymal stem cells: A review

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMohamed HusseinDubai Medical College

Discussion

Loading...

Member takes

Implication

Review synthesizes safety and efficacy of umbilical cord-derived mesenchymal stem cells in clinical settings, highlighting translational readiness.

Key Points

  • Umbilical cord–derived mesenchymal stem cells show significant efficacy in various conditions, supporting tissue repair and immune modulation.
  • Clinical trials indicate consistent safety profiles and beneficial outcomes in diseases like osteoarthritis, cirrhosis, and type 2 diabetes.
  • Challenges include small sample sizes and variability in manufacturing, necessitating larger, standardized multicenter trials to validate findings.
  • Future research should focus on combination strategies involving biomaterials and gene engineering to enhance clinical applicability.

Cite This Study

Mohamed Ziedan (2025) studied this question.

synapsesocial.com/papers/68de5da783cbc991d0a20c06https://doi.org/10.17305/bb.2025.13147
View Full Paper
Ask AI
Bookmark
Share